FIGS has recently seen its consensus analyst price target rise from $6.74 to $7.74 per share as a result of improving growth expectations. This update follows increased optimism around the company’s brand strength, growing demand, and flexible financial position, while remaining balanced against ongoing valuation concerns and market competition. Stay tuned to discover how you can keep up with the shifting narrative and what these evolving projections might mean for FIGS in the months ahead.
Recent analyst commentary on FIGS stock illustrates a mix of optimism and measured caution, with institutions weighing the company’s brand momentum and financial health against prevailing valuation concerns.
🐂 Bullish Takeaways
-
BTIG initiated coverage with a Buy rating and a $9 price target, emphasizing confidence in FIGS’s strong brand position and demand trends in the U.S. healthcare apparel market. The analyst also praised the company’s debt-free balance sheet, indicating a flexible financial foundation that can support ongoing growth.
-
Analysts at Raymond James, following meetings with FIGS management, highlighted positive operating momentum extending from the first half into the second half of 2025. Reduced discounting yielded better-than-expected results. Although the firm maintained a Market Perform rating, the outlook signaled robust long-term prospects rooted in improved execution and cost discipline.
🐻 Bearish Takeaways
-
Goldman Sachs raised its price target on FIGS from $5 to $5.50 but kept a Sell rating, underscoring persistent caution around the stock’s valuation and competitive pressures. The minor upward revision reflects some recognition of strengths but signals continued reservations about upside potential.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there’s more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!
-
FIGS, Inc. has released updated earnings guidance for the full year 2025, now projecting net revenue growth of roughly 7 percent compared to 2024.
-
The company announced an expanded partnership with Team USA and will outfit over 150 healthcare professionals at the Milano Cortina 2026 Olympic and Paralympic Winter Games. This will be the first time FIGS outfits medical teams for a Winter Games.
-
FIGS introduced FIBREx, a new innovation in fabric designed to offer improved performance and durability. The new material will make its debut in the official Team USA Medical Team kit created for the upcoming Winter Games collection.
